Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702623 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
An increased risk of developing urothelial recurrence only was recorded in patients diagnosed with CIS at RC. Physicians should consider this aspect ensuring a more severe follow-up schemes in patients who harbored this pathological feature.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Marco M.D., Shahrokh F. M.D., Mohammad M.D., Francesco M.D., Tobias M.D., Giovanni La M.D, Agostino M.D., Rocco M.D., Andrea M.D., Ph.D, Francesco M.D., Alberto M.D., Renzo M.D., Andrea M.D.,